Patients infected with HCV genotypes 2 or 3 have a 70%-80% likelihood of an SVR with a low dose of ribavirin and only 24 weeks of treatment [19, 23, 28 ]
10 Individual results vary based on starting weight, dose, diet, and activity level
The reported incidence varies across specific agents and doses, with fatigue sometimes grouped with asthenia or malaise in adverse event reporting
However, it is consistent with other studies, so it warrants further study to better understand the biological mechanisms. Public health implications The researchers acknowledged study limitations, including the potential for confounding in observational studies and the fact that several cancer types in the analysis had low event rates, leading to wide confidence intervals and limiting statistical power
Dr Davin Lim Dermatologist Brisbane | Sydney, Australia
A tracking number arrives by email at dispatch, the parcel requires a signature on delivery, and thermal packing inside the box is scaled to the season and the specific route